Perrigo Company plc

PRGO ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $1.02B $969.2M $1.11B $1.04B $1.06B $1.04B $1.14B $1.09B
Cost of Revenue $708.9M $643.7M $747.4M $666.2M $693.4M $651.6M $752.4M $683.1M
Gross Profit $313.9M $325.5M $362.2M $377.1M $362.9M $392.3M $385.9M $404.4M
Gross Margin 30.7% 33.6% 32.6% 36.1% 34.4% 37.6% 33.9% 37.2%
Operating Expenses
Research & Development $23.7M $24.6M $21.8M $24.9M $22.0M $26.7M $27.8M $26.0M
SG&A Expense $100.0M $115.0M $116.5M $94.2M $113.0M $112.2M $94.6M $116.9M
Operating Income $23.5M $-372.3M $-1.29B $72.6M $45.4M $46.9M $114.2M $80.4M
Operating Margin 2.3% -38.4% -116.0% 7.0% 4.3% 4.5% 10.0% 7.4%
Interest Expense — — — — — — — —
Pretax Income $105.4M $-408.5M $-1.33B $22.4M $3.2M $8.3M $70.1M $21.8M
Income Tax Expense $16.9M $-18.7M $82.8M $9.7M $3.7M $8.2M $111.6M $39.4M
Net Income $74.5M $-398.6M $-1.42B $7.5M $-8.4M $-6.4M $-44.4M $-21.0M
Net Margin 7.3% -41.1% -127.8% 0.7% -0.8% -0.6% -3.9% -1.9%
EPS (Basic) $0.54 $-2.87 $-10.23 $0.05 $-0.06 $-0.05 $-0.32 $-0.15
EPS (Diluted) $0.53 $-2.87 $-10.23 $0.05 $-0.06 $-0.05 $-0.32 $-0.15
Shares Outstanding (Basic) 139.1M 138.7M 138.5M 138.5M 138.2M 137.7M 137.4M 137.5M
Shares Outstanding (Diluted) 139.6M 138.7M 138.5M 138.9M 138.2M 137.7M 137.4M 137.5M
Dividends Per Share $0.29 $0.29 $0.29 $0.29 $0.29 $0.29 $0.29 $0.27
← Newer Page 1 of 8 Older →